Antiproton annihilation on light nuclei at very low energies

The recent experimental data obtained by the OBELIX group on $\bar{p}$D and $\bar{p}^4$He total annihilation cross sections are analyzed. The combined analysis of these data with existing antiprotonic atom data allows, for the first time, the imaginary parts of the S-wave scattering lengths for the two nuclei to be extracted. The obtained values are: $Im a^{sc}_0 = [- 0.62 \pm 0.02 ({stat}) \pm 0.04 ({sys})] fm$ for $\bar{p}$D and $Im a^{sc}_0 = [- 0.36\pm 0.03({stat})^{+0.19}_{-0.11}({sys})] fm$ for $\bar{p}^4$He. This analysis indicates an unexpected behaviour of the imaginary part of the $\bar{p}$-nucleus S-wave scattering length as a function of the atomic weight A: $|Im a^{sc}_0|$ ($\bar{p}$p) > $|Im a^{sc}_0|$ ($\bar{p}$D) > $|Im a^{sc}_0|$ ($\bar{p}^4$He).Comment: 13 pages, 5 figure

High-power test results of a 3 GHz single-cell cavity

Compact, reliable and little consuming accelerators are required for the treatment of tumours with ions. TERA proposes the "cyclinac", composed of a high-frequency, fast-cycling linac which boosts the energy of the particles previously accelerated in a cyclotron. The dimensions of the linac can be reduced if high gradients are used. TERA initiated a high-gradient test program to understand the operational limit of such structures. The program foresees the design, prototyping and high-power test of several high-gradient structures operating at 3 and 5.7 GHz. The high-power tests of the 3 GHz single-cell cavity were completed in Winter 2012. The maximum BDR threshold measured for Emax of 170 MV/m and RF pulses of 2.5 \mu s was 3 x 10-6 bpp/m

Lab-on-Chip for Testing Myelotoxic Effect of Drugs and Chemicals

This paper was presented at the 4th Micro and Nano Flows Conference (MNF2014), which was held at University College, London, UK. The conference was organised by Brunel University and supported by the Italian Union of Thermofluiddynamics, IPEM, the Process Intensification Network, the Institution of Mechanical Engineers, the Heat Transfer Society, HEXAG - the Heat Exchange Action Group, and the Energy Institute, ASME Press, LCN London Centre for Nanotechnology, UCL University College London, UCL Engineering, the International NanoScience Community, www.nanopaprika.eu.In the last twenty years, one of the main goals in the drug discovery field has been the development of reliable in vitro models. In particular, in 2006 the European Centre for the Validation of Alternative Methods (ECVAM) has approved the Colony forming Unit-Granulocytes-Macrophages (CFU-GM) test, which is the first and currently unique test applied to evaluate the myelotoxicity of xenobiotics in vitro. The present work aimed at miniaturizing this in vitro assay by developing and validating a Lab-on-Chip (LoC) platform consisting of a high number of bioreactor chambers with screening capabilities in a high-throughput regime